Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
J Heart Lung Transplant. 2018 Jun;37(6):685-691. doi: 10.1016/j.healun.2018.01.1294. Epub 2018 Jan 31.
The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.
第二届年度 IMACS 注册报告包含来自 35 个国家的超过 14000 名患者。本报告呈现了生存情况、不良事件和更新后的风险模型。持续流动泵继续主导全球经验。一年和两年的生存率仍保持在 80%和 70%。先天性心脏病和双心室支持是最主要的风险因素。该数据库已准备好进行主要的新分析。
